Tablet formulation
    1.
    再颁专利

    公开(公告)号:USRE29077E

    公开(公告)日:1976-12-14

    申请号:US666559

    申请日:1976-03-15

    申请人: Ehud Geller

    发明人: Ehud Geller

    IPC分类号: A61J3/10 A61K9/20

    CPC分类号: A61K9/2072 A61J3/10

    摘要: The disclosure is directed to formulations for tablets which are to be deeply grooved to facilitate breaking into predetermined portions by the user. A critical tablet weight for deeply grooved tablets is disclosed.

    Tablet formulation
    2.
    再颁专利
    Tablet formulation 失效
    片剂制剂

    公开(公告)号:USRE29076E

    公开(公告)日:1976-12-14

    申请号:US666560

    申请日:1976-03-15

    申请人: Ehud Geller

    发明人: Ehud Geller

    IPC分类号: A61J3/10 A61K9/20

    CPC分类号: A61K9/2072 A61J3/10

    摘要: The disclosure is directed to formulations for tablets which are to be deeply grooved to facilitate breaking into predetermined portions by the user. A critical tablet weight for deeply grooved tablets is disclosed.

    Intracoronary stents containing quinazolinone derivatives
    3.
    发明授权
    Intracoronary stents containing quinazolinone derivatives 失效
    冠状动脉支架含有喹唑啉酮衍生物

    公开(公告)号:US6159488A

    公开(公告)日:2000-12-12

    申请号:US325198

    申请日:1999-06-03

    CPC分类号: A61K31/517 A61F2/82

    摘要: The invention provides an intracoronary stent coated with a quinazolinone derivative of formula (I), wherein n is 1 or 2, R.sub.1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl and lower alkoxy; R.sub.2 is a member of the group consisting of hydroxy, acetoxy and lower alkoxy, and R3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl, and physiologically acceptable salts thereof, for preventing restenosis after angioplasty.

    摘要翻译: 本发明提供涂覆有式(I)的喹唑啉酮衍生物的冠状动脉内支架,其中n为1或2,R 1为氢,卤素,硝基,苯并,低级烷基,苯基和低级烷氧基的成员; R2是由羟基,乙酰氧基和低级烷氧基组成的组的成员,R3是由氢和低级链烯氧基 - 羰基组成的组的成员及其生理上可接受的盐,用于防止血管成形术后的再狭窄。